{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:19:35Z","timestamp":1773296375531,"version":"3.50.1"},"reference-count":21,"publisher":"SAGE Publications","issue":"3_suppl","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p>We describe experience with the use of mycophenolate mofetil (MMF) in neurological diseases. Although only small series of patients or case reports were described, MMF is promising in immunemediated neuromuscular disorders. MMF has been used for the treatment of polymyositis, chronic inflammatory demyelinating polyradiculoneuropathy, and multifocal motor neuropathy. These studies showed that MMF is well tolerated and may be useful in some patients. MMF can be effective alone but mainly as an adjuvant therapy by reducing steroid requirements or the frequency of infusions of IVIg. MMF has also been tested alone as a single drug treatment or in combination with immunomodulatory drugs in multiple sclerosis in open surveillance trials or in phase II studies. None of these studies have been designed to demonstrate a clinical efficacy but preliminary results are very promising.<\/jats:p>","DOI":"10.1191\/0961203305lu2117oa","type":"journal-article","created":{"date-parts":[[2005,3,14]],"date-time":"2005-03-14T22:37:13Z","timestamp":1110839833000},"page":"42-45","source":"Crossref","is-referenced-by-count":10,"title":["Mycophenolate mofetil and neurological diseases"],"prefix":"10.1177","volume":"14","author":[{"given":"P","family":"Vermersch","sequence":"first","affiliation":[{"name":"Department of Neurology and University of Lille II, H\u00f4pital Roger Salengro, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Stojkovic","sequence":"additional","affiliation":[{"name":"Department of Neurology and University of Lille II, H\u00f4pital Roger Salengro, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"De Seze","sequence":"additional","affiliation":[{"name":"Department of Neurology and University of Lille II, H\u00f4pital Roger Salengro, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2005,3]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1177\/096120330501400102"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.1.94"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(01)00478-6"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1331.2002.00478.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20024"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10026"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000134676.05850.C0"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410110205"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.4.1055"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.56.4.445"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200012)48:6<919::AID-ANA13>3.0.CO;2-J"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10313"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10026"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(200006)47:6<694::AID-ANA2>3.0.CO;2-W"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(98)01984-8"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.8.1577"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1567-5769(01)00081-9"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004150170122"},{"issue":"5","key":"e_1_2_1_20_2","first-page":"491","article-title":"Mycophenolate mofetil: an openlabel study in 42 MS patients","volume":"62","author":"Vukusic S","year":"2004","unstructured":"Vukusic S, Ducray F, Gignoux L, Mycophenolate mofetil: an openlabel study in 42 MS patients. Neurology 2004; 62(Suppl. 5): 491 (abstract P06-088).","journal-title":"Neurology"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-200403000-00006"},{"issue":"5","key":"e_1_2_1_22_2","first-page":"259","article-title":"Treatment of multiple sclerosis with a combination of interferon beta-1a (Avonex) and mycophenolate mofetil (Cellcept): results of a phase II clinical trial","volume":"62","author":"Vermersch P","year":"2004","unstructured":"Vermersch P, Waucquier N, Bourteel H, Treatment of multiple sclerosis with a combination of interferon beta-1a (Avonex) and mycophenolate mofetil (Cellcept): results of a phase II clinical trial. Neurology 2004; 62(Suppl. 5): 259 (abstract S29-001).","journal-title":"Neurology"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/0961203305LU2117OA","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1191\/0961203305LU2117OA","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T20:33:41Z","timestamp":1767645221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1191\/0961203305LU2117OA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":21,"journal-issue":{"issue":"3_suppl","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1191\/0961203305LU2117OA"],"URL":"https:\/\/doi.org\/10.1191\/0961203305lu2117oa","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}